Finance3 hrs ago

Alignment Healthcare Form 144 Shows $5.25M Sale and 596,000 Pre‑IPO Share Block

Alignment Healthcare disclosed a Form 144 showing a $5.25M sale of 250,000 shares and a 596,000-share pre‑IPO block obtained for partnership units.

David Amara/3 min/NG

Finance & Economics Editor

TweetLinkedIn

No source-linked image is attached to this story yet. Measured Take avoids generic stock art when a relevant credited image is not available.

Alignment Healthcare disclosed a Form 144 showing the sale of 250,000 shares for $5.25 million and a pre‑IPO block of 596,000 shares obtained for partnership units. The transactions occurred under Rule 144, using both a 10b5‑1 plan and individual sales in March‑April 2026.

Context

Form 144 is a notice filed with the SEC when insiders plan to sell restricted or control shares under Rule 144. Rule 144 permits affiliates to sell unregistered shares after meeting a holding period and volume limits. A 10b5‑1 plan lets insiders pre‑arrange trades to avoid accusations of insider trading.

Key Facts

On April 7, 2026, 250,000 shares were sold for $5,252,900, implying a price of about $21.01 per share. Alignment Healthcare (ticker: ALHC) closed at $21.01 on April 8, 2026, up 3.2% from the prior close, with a market capitalization of roughly $4.1 billion. The filing also notes a block of 596,000 shares originally issued before the IPO in exchange for partnership units.

What It Means

The sale price aligns closely with the market price, indicating the shares were sold at prevailing rates rather than a discount. Using a 10b5‑1 plan suggests the seller intended to diversify holdings while complying with insider‑trading rules. The pre‑IPO share block reflects early‑stage compensation for partnership contributions.

Watch for any subsequent Form 144 filings that may reveal additional sales or the completion of the disclosed block, as well as how the stock reacts to any further insider‑trading activity.

TweetLinkedIn

More in this thread

Reader notes

Loading comments...